Crohn’s Disease Clinical Research Study Underway at NYHQ

NYHQ is seeking individuals to take part in a Phase 2 clinical research study of adults with active Crohn’s disease, a chronic gastrointestinal disease with no cure.

The OPERA study will evaluate the safety and tolerability of an investigational drug and its effect on the symptoms of Crohn’s disease, particularly those related to inflammation of the gastrointestinal tract. Moshe Rubin, M.D., director, Division of Gastroenterology, is the principal investigator at NYHQ.

Individuals may be eligible to enroll in the study if they are:

  • Between 18 and 75 years old, and
  • Have active Crohn’s disease

Interested individuals can contact Ajini Cherian, research coordinator, Theresa and Eugene M. Lang Center for Research and Education, at 718-670-1827 or anc9164@nyp.org.

Take this survey to see if you are eligible for enrollment: www.pacerresearch.com/crohns

This survey is completely anonymous. This survey does not screen for every criteria, but it is the first step to determine eligibility for this study. If eligible, an individual can consent to taking part in the study and will receive follow up information on how to proceed or, an individual can opt-out of participating and record of the survey will be deleted.

 
Connect Healthcare Panacea CMS Solutions
Site Map | Contact Us | Privacy Policy | Term of Use
Copyright © 2014 New York Hospital Queens
56-45 Main Street, Flushing, NY 11355